Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Motor Activity 55Breast Neoplasms 29Neoplasms 25Lung Neoplasms 8Carcinoma, Non-Small-Cell Lung 7Colorectal Neoplasms 6Colonic Neoplasms 6Polycystic Ovary Syndrome 5Pancreatic Neoplasms 5Obesity 5Lymphoma 5Fatigue 5Multiple Myeloma 4Lymphoma, Follicular 4Lymphedema 4Esophageal Neoplasms 4Brain Neoplasms 4Stomach Neoplasms 3Prostatic Neoplasms 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Ovarian Neoplasms 3Leukemia 3Hematologic Neoplasms 3Skin Neoplasms 2Sarcopenia 2Recurrence 2Rectal Neoplasms 2Peripheral Nervous System Diseases 2Neoplasm Metastasis 2Melanoma 2

Interventions

Carboplatin 6pembrolizumab 3Paclitaxel 3Observation 3Capecitabine 3Azacitidine 3venetoclax 2pertuzumab 2olaparib 2durvalumab 2Tretinoin 2Trastuzumab 2Standard of Care 2Oxaliplatin 2Irinotecan 2Immunotherapy 2Chemoradiotherapy 2130-nm albumin-bound paclitaxel 2zanidatamab 1veliparib 1tucatinib 1trilaciclib 1trebananib 1trastuzumab duocarmazine 1toripalimab 1tislelizumab 1tegafur-gimeracil-oteracil 1taxane 1talazoparib 1tagraxofusp 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pathologic Complete Response × Exercise × 1 year × Clear all
NCT07066189 2025-10-29

Lifestyle, Exercise, And Nutrition (LEAN) Trial on Pathologic Complete Response in TNBC

Yale University

Phase NA Recruiting
160 enrolled
Breast

Pathologic Complete Response, Motor Activity, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡